Table: Chugai Pharm -Q1 group results (IFRS)

Chugai Pharmaceutical

24/04/2019 09:00

Apr 24 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2019        Mar 31, 2018     Dec 31, 2019 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              154.29              147.43                     
                   (+4.7 pct)          (+17.5 pct)                  
  Operating           46.09               38.36                     
                   (+20.2 pct)         (+45.6 pct)                  
  Pretax
  Net                 35.03               27.89                     
                   (+25.6 pct)         (+50.7 pct)                  
  EPS Basic         64.01 yen           51.00 yen                   
  EPS Diluted       63.91 yen           50.91 yen                   
  Ann Div                               86.00 yen        96.00 yen  
  -Q2 Div                               31.00 yen        48.00 yen  
  -Q4 Div                               55.00 yen        48.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T